Posts by Vivek Naranbhai, MBchB, PhD, DPhil
-
COVID-19 Vaccination Is Protective, Well Tolerated in Cancer Patients
Vivek Naranbhai, MBchB, PhD, DPhil, and colleagues found in an analysis of prospective data that COVID-19 vaccines are well tolerated in patients with cancer and most recipients are likely to be protected against severe disease, although non-mRNA vaccines and some therapies may impair responses.
Biography
Vivek Naranbhai, MBchB, PhD, DPhil, is an oncologist in the Mass General Cancer Center and instructor in medicine at Harvard Medical School.